Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus

American Journal of Cardiology

Volumn 106, Issue 8, 2010, Pages 1118-1123

  Bagheri, Roshanak ^a   Qasim, Atif N ^a   Mehta, Nehal N ^a   Terembula, Karen ^a   Kapoor, Shiv ^b   Braunstein, Seth ^a   Schutta, Mark ^a   Iqbal, Nayyar ^a   Lehrke, Michael ^b   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FABP4 PROTEIN, HUMAN; FABP5 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WAIST CIRCUMFERENCE; ANGIOCARDIOGRAPHY; BLOOD; CALCINOSIS; COMPARATIVE STUDY; COMPLICATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; PROGNOSIS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

AGED; BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 77957752986     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.028     Document Type: Article

References (27)

1. J.B. Boord, K. Maeda, L. Makowski, V.R. Babaev, S. Fazio, M.F. Linton, and G.S. Hotamisligil Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice Circulation 110 2004 1492 1498
2. E. Erbay, H. Cao, and G.S. Hotamisligil Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome Curr Atheroscler Rep 9 2007 222 229
3. M. Furuhashi, G. Tuncman, C.Z. Gorgun, L. Makowski, G. Atsumi, E. Vaillancourt, K. Kono, V.R. Babaev, S. Fazio, M.F. Linton, R. Sulsky, J.A. Robl, R.A. Parker, and G.S. Hotamisligil Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 2007 959 965
4. G.S. Hotamisligil, R.S. Johnson, R.J. Distel, R. Ellis, V.E. Papaioannou, and B.M. Spiegelman Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein Science 274 1996 1377 1379
5. K. Maeda, H. Cao, K. Kono, C.Z. Gorgun, M. Furuhashi, K.T. Uysal, Q. Cao, G. Atsumi, H. Malone, B. Krishnan, Y. Minokoshi, B.B. Kahn, R.A. Parker, and G.S. Hotamisligil Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes Cell Metab 1 2005 107 119
6. A. Xu, A.W. Tso, B.M. Cheung, Y. Wang, N.M. Wat, C.H. Fong, D.C. Yeung, E.D. Janus, P.C. Sham, and K.S. Lam Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study Circulation 115 2007 1537 1543
7. A.W. Tso, A. Xu, P.C. Sham, N.M. Wat, Y. Wang, C.H. Fong, B.M. Cheung, E.D. Janus, and K.S. Lam Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort Diabetes Care 30 2007 2667 2672
8. G. Tuncman, E. Erbay, X. Hom, I. De Vivo, H. Campos, E.B. Rimm, and G.S. Hotamisligil A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease Proc Natl Acad Sci U S A 103 2006 6970 6975
9. M.P. Reilly, N. Iqbal, M. Schutta, M.L. Wolfe, M. Scally, A.R. Localio, D.J. Rader, and S.E. Kimmel Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 2004 3872 3878
10. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
11. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. Spertus, and F. Costa Diagnosis and management of the metabolic syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary Cardiol Rev 13 2005 322 327 (Pubitemid 41579599)
12. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr, and R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832
13. M.P. Reilly, M.L. Wolfe, A.R. Localio, and D.J. Rader Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach Atherosclerosis 173 2004 69 78
14. J.A. Hoff, L. Quinn, A. Sevrukov, R.B. Lipton, M. Daviglus, D.B. Garside, N.K. Ajmere, S. Gandhi, and G.T. Kondos The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease J Am Coll Cardiol 41 2003 1008 1012
15. J.B. Meigs, M.G. Larson, R.B. D'Agostino, D. Levy, M.E. Clouse, D.M. Nathan, P.W. Wilson, and C.J. O'Donnell Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study Diabetes Care 25 2002 1313 1319
16. M. Furuhashi, R. Fucho, C.Z. Gorgun, G. Tuncman, H. Cao, and G.S. Hotamisligil Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice J Clin Invest 118 2008 2640 2650
17. L. Makowski, J.B. Boord, K. Maeda, V.R. Babaev, K.T. Uysal, M.A. Morgan, R.A. Parker, J. Suttles, S. Fazio, G.S. Hotamisligil, and M.F. Linton Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis Nat Med 7 2001 699 705
18. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
19. L. Makowski, K.C. Brittingham, J.M. Reynolds, J. Suttles, and G.S. Hotamisligil The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities J Biol Chem 280 2005 12888 12895
20. M.D. Layne, A. Patel, Y.H. Chen, V.I. Rebel, I.M. Carvajal, A. Pellacani, B. Ith, D. Zhao, B.M. Schreiber, S.F. Yet, M.E. Lee, J. Storch, and M.A. Perrella Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice FASEB J 15 2001 2733 2735
21. K. Maeda, K.T. Uysal, L. Makowski, C.Z. Gorgun, G. Atsumi, R.A. Parker, J. Bruning, A.V. Hertzel, D.A. Bernlohr, and G.S. Hotamisligil Role of the fatty acid binding protein mal1 in obesity and insulin resistance Diabetes 52 2003 300 307
22. H. Cao, K. Maeda, C.Z. Gorgun, H.J. Kim, S.Y. Park, G.I. Shulman, J.K. Kim, and G.S. Hotamisligil Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice Diabetes 55 2006 1915 1922
23. D.C. Yeung, A. Xu, C.W. Cheung, N.M. Wat, M.H. Yau, C.H. Fong, M.T. Chau, and K.S. Lam Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis Arterioscler Thromb Vasc Biol 27 2007 1796 1802
24. E.J. Rhee, W.Y. Lee, C.Y. Park, K.W. Oh, B.J. Kim, K.C. Sung, and B.S. Kim The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults Eur J Endocrinol 160 2009 165 172
25. M.J. Budoff, K. Nasir, R.L. McClelland, R. Detrano, N. Wong, R.S. Blumenthal, G. Kondos, and R.A. Kronmal Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 53 2009 345 352
26. R.S. Elkeles, I.F. Godsland, M.D. Feher, M.B. Rubens, M. Roughton, F. Nugara, S.E. Humphries, W. Richmond, and M.D. Flather Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study Eur Heart J 29 2008 2244 2251
27. A. Cabre, I. Lazaro, J. Girona, J.M. Manzanares, F. Marimon, N. Plana, M. Heras, and L. Masana Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria Clin Chem 54 2008 181 187